HRES 928 119th Congress
Affirming support for most-favored-Nation drug pricing for United States patients.
Latest Action
Referred to the House Committee on Energy and Commerce.
Sponsors
Actions
2025-12-04T00:00:00
Referred to the House Committee on Energy and Commerce.
2025-12-04T00:00:00
Submitted in House
2025-12-04T00:00:00
Submitted in House
Policy Areas
Health
![Rep. Dingell, Debbie [D-MI-6]](https://bioguide.congress.gov/bioguide/photo/D/D000624.jpg)